Your browser doesn't support javascript.
loading
The Safety of available immunotherapy for the treatment of glioblastoma.
Farber, S Harrison; Elsamadicy, Aladine A; Atik, Ahmet Fatih; Suryadevara, Carter M; Chongsathidkiet, Pakawat; Fecci, Peter E; Sampson, John H.
Afiliação
  • Farber SH; a Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery , Duke University Medical Center , Durham , NC , USA.
  • Elsamadicy AA; b The Preston Robert Tisch Brain Tumor Center , Duke University Medical Center , Durham , NC , USA.
  • Atik AF; a Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery , Duke University Medical Center , Durham , NC , USA.
  • Suryadevara CM; b The Preston Robert Tisch Brain Tumor Center , Duke University Medical Center , Durham , NC , USA.
  • Chongsathidkiet P; a Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery , Duke University Medical Center , Durham , NC , USA.
  • Fecci PE; b The Preston Robert Tisch Brain Tumor Center , Duke University Medical Center , Durham , NC , USA.
  • Sampson JH; a Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery , Duke University Medical Center , Durham , NC , USA.
Expert Opin Drug Saf ; 16(3): 277-287, 2017 Mar.
Article em En | MEDLINE | ID: mdl-27989218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Imunoterapia Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Imunoterapia Idioma: En Ano de publicação: 2017 Tipo de documento: Article